PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY END-USER Market segmentation by end-user Comparison by end-user Hospitals - Market size and forecast 2018-2023 Physicians' office laboratories - Market size and forecast 2018-2023 Clinical diagnostic laboratories - Market size and forecast 2018-2023 Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Growing demand for POC testing Technological advances in fecal occult tests for CRC screening Availability of a broad range of CRC screening products PART 12: VENDOR LANDSCAPE Overview Landscape disruption PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Abbott Laboratories bioMérieux SA Danaher Corp. Eiken Chemical Co. Ltd. Quidel Corp. PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global healthcare market Exhibit 02: Segments of global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Hospitals - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Hospitals - Year-over-year growth 2019-2023 (%) Exhibit 21: Physicians' office laboratories - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Physicians' office laboratories - Year-over-year growth 2019-2023 (%) Exhibit 23: Clinical diagnostic laboratories - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Clinical diagnostic laboratories - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Abbott Laboratories - Vendor overview Exhibit 46: Abbott Laboratories - Business segments Exhibit 47: Abbott Laboratories - Organizational developments Exhibit 48: Abbott Laboratories - Geographic focus Exhibit 49: Abbott Laboratories - Segment focus Exhibit 50: Abbott Laboratories - Key offerings Exhibit 51: bioMérieux SA - Vendor overview Exhibit 52: bioMérieux SA - Business segments Exhibit 53: bioMérieux SA - Organizational developments Exhibit 54: bioMérieux SA - Geographic focus Exhibit 55: bioMérieux SA - Key offerings Exhibit 56: Danaher Corp. - Vendor overview Exhibit 57: Danaher Corp. - Business segments Exhibit 58: Danaher Corp. - Organizational developments Exhibit 59: Danaher Corp. - Geographic focus Exhibit 60: Danaher Corp. - Segment focus Exhibit 61: Danaher Corp. - Key offerings Exhibit 62: Eiken Chemical Co. Ltd. - Vendor overview Exhibit 63: Eiken Chemical Co. Ltd. - Business segments Exhibit 64: Eiken Chemical Co. Ltd. - Organizational developments Exhibit 65: Eiken Chemical Co. Ltd. - Geographic focus Exhibit 66: Eiken Chemical Co. Ltd. - Key offerings Exhibit 67: Quidel Corp. - Vendor overview Exhibit 68: Quidel Corp. - Business segments Exhibit 69: Quidel Corp. - Organizational developments Exhibit 70: Quidel Corp. - Geographic focus Exhibit 71: Quidel Corp. - Key offerings Exhibit 72: Validation techniques employed for market sizing Exhibit 73: Definition of market positioning of vendors

Abbott Laboratories, bioMérieux SA, Danaher Corp., Eiken Chemical Co. Ltd., and Quidel Corp.